Terlipressin and albumin combination treatment in patients with hepatorenal syndrome type 2

BACKGROUND: Hepatorenal syndrome (HRS) is associated with a poor prognosis. In HRS type 1, loss of renal function is rapidly progressive, while HRS type 2 is characterised by chronic ascites and more moderately elevated renal parameters. While treatment with terlipressin/albumin is well established...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:United European Gastroenterol J
Main Authors: Nguyen-Tat, Marc, Jäger, Julia, Rey, Johannes Wilhelm, Nagel, Michael, Labenz, Christian, Wörns, Marcus-Alexander, Galle, Peter Robert, Marquardt, Jens Uwe
Format: Artigo
Jezik:Inglês
Izdano: SAGE Publications 2019
Teme:
Original Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6488797/
https://ncbi.nlm.nih.gov/pubmed/31065370
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640619825719
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki